Zydus Lifesciences to Acquire Assertio Holdings in $166.4 Million Deal, Bolstering US Presence
Zydus Lifesciences, a prominent Indian pharmaceutical company, announced its definitive agreement to acquire US-based specialty pharmaceutical firm Assertio Holdings for $23.5 per share in cash, valuing the transaction at approximately $166.4 million. This strategic move, which has made ‘today’ and May 19 important sessions for Zydus Life shareholders, aims to significantly expand Zydus’s footprint in…